https://www.ophthalmologytimes.com/view/fda-approves-zeiss-aspheric-monofocal-single-piece-c-loop-iol 2023-04-26 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-ocular-blood-flow-and-its-relationship-to-acute-coronary-syndrome 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-early-detection-of-diabetic-retinopathy-in-underserved-communities 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-predictive-ai-algorithms-and-data-interpretation 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-analysis-of-vision-loss-from-gather-clinical-program 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-visual-function-imaging-and-artificial-intelligence-with-apellis 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-insight-into-cell-death-with-amd 2023-04-25 0.50 https://www.ophthalmologytimes.com/view/smoking-poses-a-greater-risk-of-surgery-for-thyroid-eye-disease 2023-04-21 0.50 https://www.ophthalmologytimes.com/view/retinal-vein-occlusion-occurrence-is-rare-after-covid-19-vaccine 2023-04-20 0.50 https://www.ophthalmologytimes.com/view/two-faricimab-patient-cases-from-the-real-world-in-neovascular-amd 2023-05-01 0.50 https://www.ophthalmologytimes.com/view/study-design-and-preliminary-results-from-the-truckee-study-evaluating-faricimab-in-real-world-neovascular-amd-patients 2023-05-01 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-let-the-poster-presentations-begin 2023-04-18 0.50 https://www.ophthalmologytimes.com/view/arvo-2023-social-and-networking-events-abound-during-conference 2023-04-18 0.50 https://www.ophthalmologytimes.com/view/how-decreased-cone-densities-may-help-detect-and-monitor-multiple-sclerosis 2023-04-17 0.50 https://www.ophthalmologytimes.com/view/paediatric-retinal-disease-a-slow-and-steady-evolution-of-diagnostics-and-treatments 2023-04-26 0.50 https://www.ophthalmologytimes.com/view/successful-presbyopia-correction-after-hyperopic-lasik-using-the-at-lara-edof-iol 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/the-role-of-crystalline-lens-power-as-a-primary-driver-of-refractive-error-in-laser-treated-rop 2023-04-13 0.50 https://www.ophthalmologytimes.com/view/researchers-receive-funding-to-continue-work-for-sight-loss-breakthrough 2023-04-11 0.50 https://www.ophthalmologytimes.com/view/how-low-dose-atropine-drops-may-have-a-positive-impact-on-myopia-progression 2023-04-09 0.50 https://www.ophthalmologytimes.com/view/breaking-the-cycle-of-chronic-eye-rubbing 2023-04-06 0.50 https://www.ophthalmologytimes.com/view/using-ai-to-estimate-severity-of-graves-orbitopathy 2023-04-05 0.50 https://www.ophthalmologytimes.com/view/alimera-expands-agreement-with-horus-pharma-to-include-marketing-iluvien-in-the-nordic-countries 2023-04-03 0.50 https://www.ophthalmologytimes.com/view/new-approach-to-foveal-holes-light-sound-and-nutraceuticals 2023-03-31 0.50 https://www.ophthalmologytimes.com/view/lessons-from-the-togo-glaucoma-project 2023-03-30 0.50 https://www.ophthalmologytimes.com/view/new-strategies-for-severe-ocular-surface-and-corneal-disease 2023-03-30 0.50 https://www.ophthalmologytimes.com/view/addressing-the-challenge-of-patient-compliance-with-topical-ophthalmic-drugs 2023-03-28 0.50 https://www.ophthalmologytimes.com/view/cophy-2023-managing-amd-with-home-monitoring 2023-03-30 0.50 https://www.ophthalmologytimes.com/view/cophy-2023-considering-thyroid-eye-disease-and-teprotumumab-for-all-patients 2023-03-30 0.50 https://www.ophthalmologytimes.com/view/cophy-2023-restorative-therapies-and-the-path-to-them 2023-03-21 0.50 https://www.ophthalmologytimes.com/view/cophy-2023-presence-of-macular-neovascularization-on-octa-is-predictive-of-subsequent-exudation 2023-03-28 0.50 https://www.ophthalmologytimes.com/view/cophy-2023-durability-associated-with-multi-target-therapies-is-superior-to-anti-vegf-mono-target-therapy-in-amd 2023-03-21 0.50 https://www.ophthalmologytimes.com/view/how-deep-learning-may-play-a-role-in-estimating-retinitis-pigmentosa-progression 2023-03-22 0.50 https://www.ophthalmologytimes.com/view/recognising-faces-may-be-problematic-for-some-after-long-covid 2023-03-21 0.50 https://www.ophthalmologytimes.com/view/the-advantages-of-a-digital-workflow-in-modern-cataract-surgery 2024-04-19 0.50 https://www.ophthalmologytimes.com/view/choosing-the-right-iol-for-the-right-patient-visual-performance-and-stability-of-a-modified-aspheric-monofocal-iol 2024-04-19 0.50 https://www.ophthalmologytimes.com/view/anterior-chamber-stability-and-safe-cataract-surgery 2024-04-19 0.50 https://www.ophthalmologytimes.com/view/weighing-the-link-among-metabolic-health-obesity-and-iop 2023-03-17 0.50 https://www.ophthalmologytimes.com/view/preparing-for-surgical-success 2024-04-19 0.50 https://www.ophthalmologytimes.com/view/paying-attention-to-ocular-surface-disease-preoperatively-matters 2023-03-16 0.50 https://www.ophthalmologytimes.com/view/countdown-to-cophy-2023-let-the-evidence-based-debates-and-discussions-begin 2023-03-16 0.50 https://www.ophthalmologytimes.com/view/canaloplasty-putting-together-a-complete-surgical-picture 2023-03-14 0.50 https://www.ophthalmologytimes.com/view/smartphone-based-fundus-camera-puts-glaucoma-screening-in-the-palm-of-clinician-hands 2023-03-10 0.50 https://www.ophthalmologytimes.com/view/large-scale-study-focuses-on-new-insights-into-rare-eye-disorders 2023-03-10 0.50 https://www.ophthalmologytimes.com/view/ophtec-celebrates-milestone-anniversary-poised-for-future-with-new-brand-identity 2023-03-10 0.50 https://www.ophthalmologytimes.com/view/the-ins-and-outs-of-gene-therapy-for-inherited-optic-neuropathies 2023-03-16 0.50 https://www.ophthalmologytimes.com/view/grifols-enters-into-global-collaboration-and-licensing-agreement-with-selagine-to-develop-immunoglobulin-eye-drops-to-treat-dry-eye-disease 2023-03-06 0.50 https://www.ophthalmologytimes.com/view/making-the-diagnosis-bilateral-blurry-vision-in-a-9-year-old-boy 2023-03-04 0.50 https://www.ophthalmologytimes.com/view/understanding-schlemm-canal-to-improve-the-results-of-stent-surgery 2023-03-04 0.50 https://www.ophthalmologytimes.com/view/keratoconus-intrastromal-implantation-of-fresh-human-lenticules 2023-03-01 0.50 https://www.ophthalmologytimes.com/view/novel-corneal-refractive-technology-from-johnson-johnson-vision-receives-ce-mark-approval 2023-03-01 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-high-dose-aflibercept-demonstrates-safety-efficacy-in-treatment-of-dme 2023-02-28 0.50 https://www.ophthalmologytimes.com/view/apao-2023-keralink-trial-and-efficacy-safety-of-corneal-cross-linking-for-children-with-keratoconus 2023-02-24 0.50 https://www.ophthalmologytimes.com/view/apao-2023-probe-with-beveled-tip-offers-surgeons-an-all-in-one-instrument-for-retinal-detachment-vitrectomy 2023-02-22 0.50 https://www.ophthalmologytimes.com/view/apao-2023-study-finds-diffuse-atrophy-in-children-may-be-path-to-development-of-pathologic-myopia-in-adults 2023-02-22 0.50 https://www.ophthalmologytimes.com/view/apao-2023-looking-at-retinoblastoma-in-2023 2023-02-21 0.50 https://www.ophthalmologytimes.com/view/2023-apao-social-events 2023-02-16 0.50 https://www.ophthalmologytimes.com/view/asia-pacific-academy-of-ophthalmology-to-reconnect-and-collaborate-with-return-to-live-events 2023-02-13 0.50 https://www.ophthalmologytimes.com/view/cohort-study-considering-if-dietary-nitrate-intake-is-associated-with-progression-of-amd 2023-02-20 0.50 https://www.ophthalmologytimes.com/view/fda-approves-apellis-pegcetacoplan-for-geographic-atrophy-therapy 2023-02-17 0.50 https://www.ophthalmologytimes.com/view/asia-pacific-academy-of-ophthalmology-2023-reconnect-and-collaborate 2023-02-16 0.50 https://www.ophthalmologytimes.com/view/case-3-faricimab-in-a-neovascular-namd-patient-with-persistent-fluid 2023-02-16 0.50 https://www.ophthalmologytimes.com/view/case-2-faricimab-in-treatment-na-ve-neovascular-namd-patient 2023-02-16 0.50 https://www.ophthalmologytimes.com/view/case-1-faricimab-in-a-high-need-neovascular-namd-patient 2023-02-20 0.50 https://www.ophthalmologytimes.com/view/envision-summit-2023-bringing-ophthalmology-together 2023-02-13 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2023-dry-amd-and-ellipsoid-zone-integrity 2023-02-09 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2023-clinical-trial-data-from-derby-oaks-for-geographic-atrophy 2023-02-09 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2023-what-the-talon-phase-3b-study-results-mean-for-neovascular-amd 2023-02-09 0.50 https://www.ophthalmologytimes.com/view/uncovering-the-mystery-surrounding-geographic-atrophy 2023-02-07 0.50 https://www.ophthalmologytimes.com/view/investigators-explore-use-of-ophthalmic-artery-angioplasty-to-treat-amd 2023-02-07 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2023-study-examines-ga-phenotypes-and-progression-rates-in-asians-non-asians 2023-02-09 0.50 https://www.ophthalmologytimes.com/view/aflibercept-approval-expands-treatment-options-for-patients-with-rop 2023-02-10 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-aflibercept-therapy-for-preterm-infants-with-rop 2023-02-10 0.50 https://www.ophthalmologytimes.com/view/retinal-imaging-to-detect-alzheimer-disease-machine-learning-model 2023-02-08 0.50 https://www.ophthalmologytimes.com/view/glaucoma-360-eyedrop-targets-and-reduces-episcleral-venous-pressure-in-glaucoma 2023-02-08 0.50 https://www.ophthalmologytimes.com/view/considering-cataract-surgery-and-reduction-of-dementia-in-europe 2023-02-04 0.50 https://www.ophthalmologytimes.com/view/glaucoma-360-glaucoma-progression-from-hypotension 2023-02-01 0.50 https://www.ophthalmologytimes.com/view/dry-amd-a-review-of-ongoing-completed-and-future-treatments 2023-02-07 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-to-ml6710i-laser-for-use-with-visudyne 2023-02-01 0.50 https://www.ophthalmologytimes.com/view/atropine-instillation-after-glaucoma-surgery-may-impair-vision-prolong-rehabilitation-time 2023-01-30 0.50 https://www.ophthalmologytimes.com/view/disparities-in-availability-of-paediatric-eye-care-us-report 2023-01-30 0.50 https://www.ophthalmologytimes.com/view/cataract-surgery-in-cambodia-achieving-quality-outcomes-in-a-challenging-setting-with-the-ct-lucia-621p 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/inherited-retinal-diseases-progress-being-made-with-treatment-modalities 2023-01-25 0.50 https://www.ophthalmologytimes.com/view/exploring-robotic-fractionated-radiotherapy-for-benign-ocular-tumours 2023-01-23 0.50 https://www.ophthalmologytimes.com/view/case-series-study-managing-a-fungal-endophthalmitis-outbreak 2023-01-20 0.50 https://www.ophthalmologytimes.com/view/winners-of-2023-arvo-research-fellowships-announced 2023-01-18 0.50 https://www.ophthalmologytimes.com/view/corneal-ecd-decrease-continues-after-iris-fixated-phakic-iol-explanation 2023-01-20 0.50 https://www.ophthalmologytimes.com/view/what-retinal-vasculature-changes-may-mean-for-cognitive-impairment 2023-01-13 0.50 https://www.ophthalmologytimes.com/view/identifying-herpesvirus-dna-in-corneal-grafts 2023-01-10 0.50 https://www.ophthalmologytimes.com/view/elios-vision-announces-elios-registration-in-the-united-kingdom 2023-01-07 0.50 https://www.ophthalmologytimes.com/view/why-patients-with-inflammatory-bowel-disease-might-need-to-see-their-ophthalmologist 2023-01-04 0.50 https://www.ophthalmologytimes.com/view/imaging-shows-ocular-changes-in-chronic-thromboembolic-pulmonary-hypertension 2022-12-26 0.50 https://www.ophthalmologytimes.com/view/treating-persistent-macular-holes-with-heavy-silicone-oil 2022-12-26 0.50 https://www.ophthalmologytimes.com/view/how-systemic-comorbidities-may-affect-conversion-from-oht-to-oag 2022-12-26 0.50 https://www.ophthalmologytimes.com/view/local-resection-of-choroidal-melanoma-weighing-the-pros-and-cons 2022-12-26 0.50 https://www.ophthalmologytimes.com/view/the-more-you-know-expanding-knowledge-about-rop-development-progression 2022-12-20 0.50 https://www.ophthalmologytimes.com/view/elios-vision-announces-elios-registration-in-france 2022-12-20 0.50 https://www.ophthalmologytimes.com/view/long-term-efficacy-and-durability-of-latest-therapies-in-neovascular-amd-and-dmo 2023-01-27 0.50 https://www.ophthalmologytimes.com/view/shedding-light-on-removal-of-foldable-iols-annual-survey 2022-12-16 0.50 https://www.ophthalmologytimes.com/view/apellis-submits-marketing-authorisation-application-to-the-european-medicines-agency-for-pegcetacoplan-for-geographic-atrophy 2022-12-17 0.50 https://www.ophthalmologytimes.com/view/fda-approval-thea-s-preservative-free-latanoprost-for-iop-reduction-in-oag-ocular-hypertension 2022-12-16 0.50 https://www.ophthalmologytimes.com/view/the-truth-about-invisible-posterior-vitreous-structures 2022-12-10 0.50 https://www.ophthalmologytimes.com/view/optimising-the-ocular-surface-to-achieve-good-vision-after-surgery 2022-12-10 0.50 https://www.ophthalmologytimes.com/view/2023-what-awaits-ophthalmology-in-the-year-ahead 2022-12-20 0.50 https://www.ophthalmologytimes.com/view/health-disparities-impact-of-the-pandemic-on-paediatric-ophthalmic-visits 2022-12-10 0.50 https://www.ophthalmologytimes.com/view/new-goniotomy-device-careful-post-op-care-limits-intraoperative-bleeding 2022-12-07 0.50 https://www.ophthalmologytimes.com/view/what-patients-do-and-don-t-know-about-stem-cell-therapy 2022-12-06 0.50 https://www.ophthalmologytimes.com/view/myth-or-reality-corneal-refractive-surgery-to-manage-presbyopic-patients 2022-12-06 0.50 https://www.ophthalmologytimes.com/view/discussion-on-the-real-world-use-of-faricimab-with-dr-khanani-and-dr-khoramnia 2023-02-17 0.50 https://www.ophthalmologytimes.com/view/filling-in-the-knowledge-gaps-biosimilars-awareness-for-retinal-disease-in-the-us-and-europe 2022-12-02 0.50 https://www.ophthalmologytimes.com/view/self-tonometry-provides-invaluable-insights-into-iop-fluctuations 2022-11-30 0.50 https://www.ophthalmologytimes.com/view/a-history-of-discovery-why-abbvie-focuses-on-challenging-eye-care-diseases 2022-11-28 0.50 https://www.ophthalmologytimes.com/view/re-vana-therapeutics-raises-11-9-million-to-advance-ophthalmic-technology-platforms 2022-12-06 0.50 https://www.ophthalmologytimes.com/view/biosimilars-what-clinicians-should-know 2023-03-03 0.50 https://www.ophthalmologytimes.com/view/spotlight-on-ga-a-bright-future-with-potential-treatments 2022-11-17 0.50 https://www.ophthalmologytimes.com/view/cataract-predictability-screen-and-treat-unstable-tear-film-in-weeks 2022-11-17 0.50 https://www.ophthalmologytimes.com/view/controlling-the-growing-problem-of-myopia-in-children 2022-11-17 0.50 https://www.ophthalmologytimes.com/view/causes-of-ocular-inflammation-linked-to-aav-gene-therapy 2022-11-16 0.50 https://www.ophthalmologytimes.com/view/the-pathophysiology-and-pathomorphology-of-corneal-ectasia-part-4 2022-11-14 0.50 https://www.ophthalmologytimes.com/view/ovd-bolus-putting-the-eye-to-the-grindstone 2022-11-09 0.50 https://www.ophthalmologytimes.com/view/selecting-the-right-topical-glaucoma-therapy-is-important 2022-11-07 0.50 https://www.ophthalmologytimes.com/view/seize-under-utilised-opportunity-to-treat-glaucoma-during-vitrectomy 2022-11-08 0.50 https://www.ophthalmologytimes.com/view/weekly-review-in-ophthalmology 2022-11-03 0.50 https://www.ophthalmologytimes.com/view/identifying-herpes-simplex-virus-keratitis-in-keratoconus-surgery-patients 2022-11-02 0.50 https://www.ophthalmologytimes.com/view/assessing-barriers-to-retinal-care-during-a-pandemic 2022-11-01 0.50 https://www.ophthalmologytimes.com/view/automating-ultrasound-delivery-for-increased-efficiency-in-my-cataract-surgeries-power-on-demand-with-the-zeiss-quatera-700 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/retinal-camera-unlocks-back-of-the-eye-secrets 2022-10-31 0.50 https://www.ophthalmologytimes.com/view/zeiss-quatera-700-power-on-demand 2022-11-01 0.50 https://www.ophthalmologytimes.com/view/how-to-juggle-simultaneous-treatments-for-dry-eye-glaucoma 2022-10-28 0.50 https://www.ophthalmologytimes.com/view/systemic-factors-not-predictive-of-va-outcomes-following-cataract-surgery-in-patients-with-diabetic-retinopathy 2022-10-28 0.50 https://www.ophthalmologytimes.com/view/knowing-when-to-refer-young-patients-to-ocular-genetics-programmes 2022-10-25 0.50 https://www.ophthalmologytimes.com/view/robotic-telepresence-gain-acceptance-during-ocular-evaluations 2022-10-25 0.50 https://www.ophthalmologytimes.com/view/tried-and-tested-therapeutic-options-for-meibomian-gland-dysfunction 2022-10-24 0.50 https://www.ophthalmologytimes.com/view/eye-drop-that-reaches-posterior-ocular-tissues-could-protect-retinal-cells 2022-10-20 0.50 https://www.ophthalmologytimes.com/view/effect-of-drusen-and-atrophy-on-automated-segmentation-in-oct-images 2022-10-19 0.50 https://www.ophthalmologytimes.com/view/driving-practice-growth-the-connection-between-dry-eye-and-aesthetics 2022-10-18 0.50 https://www.ophthalmologytimes.com/view/ai-and-teleophthalmology-appear-comparable-to-in-person-dr-diagnoses 2022-10-12 0.50 https://www.ophthalmologytimes.com/view/pearls-for-minimally-invasive-strabismus-surgery 2022-10-14 0.50 https://www.ophthalmologytimes.com/view/disrupting-the-glaucoma-treatment-paradigm-with-novel-femtosecond-laser-from-vialase 2022-10-11 0.50 https://www.ophthalmologytimes.com/view/trukera-medical-rebranding-ushers-in-new-era-of-expansion-into-cornea-market 2022-10-14 0.50 https://www.ophthalmologytimes.com/view/donations-aid-in-global-vision-crisis-on-world-sight-day 2022-10-12 0.50 https://www.ophthalmologytimes.com/view/what-world-sight-day-means-to-ophthalmologists-and-optometrists 2022-10-12 0.50 https://www.ophthalmologytimes.com/view/2-year-data-in-contralateral-eye-evaluation-gives-edge-to-istent-inject-over-hydrus-stent 2022-10-11 0.50 https://www.ophthalmologytimes.com/view/considerations-when-using-iols-in-patients-with-complex-corneas 2022-10-10 0.50 https://www.ophthalmologytimes.com/view/scleral-lens-technology-and-keratoconus-a-life-changing-option-for-patients 2022-10-04 0.50 https://www.ophthalmologytimes.com/view/ophthalmic-evaluation-recommended-for-young-patients-with-brain-tumours 2022-09-26 0.50 https://www.ophthalmologytimes.com/view/innovative-technology-for-the-hearing-impaired-makes-use-of-visual-cues 2022-10-04 0.50 https://www.ophthalmologytimes.com/view/aao-recap-clinical-trial-updates-new-innovations-presented-at-america-s-biggest-ophthalmic-conference 2022-10-04 0.50 https://www.ophthalmologytimes.com/view/optogenetics-approach-could-restore-visual-function-in-retinitis-pigmentosa 2022-10-03 0.50 https://www.ophthalmologytimes.com/view/no-negative-effects-in-dmo-patients-reported-following-pandemic-imposed-health-care-restrictions 2022-10-02 0.50 https://www.ophthalmologytimes.com/view/risk-factors-for-developing-rhegmatogenous-retinal-detachments-in-fellow-eyes-identified-in-study 2022-10-02 0.50 https://www.ophthalmologytimes.com/view/increased-smoking-related-ocular-symptoms-linked-to-cigarettes-than-electronic-cigarettes 2022-10-03 0.50 https://www.ophthalmologytimes.com/view/pooled-tenaya-lucerne-phase-3-data-reports-safety-efficacy-lower-treatment-burden-with-faricimab-for-namd 2022-10-02 0.50 https://www.ophthalmologytimes.com/view/younger-patients-often-require-repeat-corneal-crosslinking-study-finds 2022-09-28 0.50 https://www.ophthalmologytimes.com/view/retinal-detachment-rates-following-acute-retinal-necrosis-are-unaffected-by-early-treatment-with-antivirals-vitrectomy 2022-09-29 0.50 https://www.ophthalmologytimes.com/view/is-the-robot-assisted-procedure-the-future-of-migs- 2022-09-28 0.50 https://www.ophthalmologytimes.com/view/investigators-report-positive-visual-outcomes-one-year-after-monocular-implantation-of-small-aperture-iol 2022-09-29 0.50 https://www.ophthalmologytimes.com/view/fluid-dynamics-in-wet-macular-degeneration-how-fluid-type-affects-visual-acuity 2022-10-01 0.50 https://www.ophthalmologytimes.com/view/utilising-aao-cornea-preferred-practice-patterns-for-corneal-oedema-opacifications-ectasia-and-bacterial-keratits 2022-10-04 0.50 https://www.ophthalmologytimes.com/view/comparing-dry-eye-disease-in-adult-and-paediatric-populations-via-the-iris-registry 2022-09-30 0.50 https://www.ophthalmologytimes.com/view/higher-incidence-of-new-strabismus-in-paediatric-patients-following-tube-shunt-surgery 2022-09-30 0.50 https://www.ophthalmologytimes.com/view/poor-post-pandemic-follow-up-care-in-glaucoma-patients-prompts-concern 2022-09-23 0.50 https://www.ophthalmologytimes.com/view/corneal-ectasia-part-3-oct-epithelial-thickness-measurements-allow-monitoring-of-corneal-changes 2022-09-23 0.50 https://www.ophthalmologytimes.com/view/should-endocyclophotocoagulation-be-considered-part-of-migs-mr-ratnarajan-delves-in 2022-09-26 0.50 https://www.ophthalmologytimes.com/view/genetic-testing-for-keratoconus-facilitates-earlier-recognition-of-condition 2022-09-23 0.50 https://www.ophthalmologytimes.com/view/mont-blanc-final-visit-completed-in-phase-3-trial-of-ncx-470-for-the-treatment-of-glaucoma 2022-09-22 0.50 https://www.ophthalmologytimes.com/view/investigating-better-indications-and-outcomes-in-laser-refractive-surgery 2022-09-23 0.50 https://www.ophthalmologytimes.com/view/investigating-the-effects-of-canaloplasty-on-corneal-epithelium 2022-09-22 0.50 https://www.ophthalmologytimes.com/view/avoiding-errors-when-converting-to-dmek 2022-09-21 0.50 https://www.ophthalmologytimes.com/view/edof-lens-tech-is-evolving-to-help-more-patients-with-intermediate-vision 2022-09-27 0.50 https://www.ophthalmologytimes.com/view/circumnavigating-the-bumpy-road-to-vernal-keratoconjunctivitis-time-is-key 2022-09-16 0.50 https://www.ophthalmologytimes.com/view/faricimab-approved-for-treatment-of-namd-dmo-by-european-commission 2022-09-21 0.50 https://www.ophthalmologytimes.com/view/fixoflex-ring-prof-pallikaris-describes-how-to-utilise-the-device-during-iol-implantation 2022-09-21 0.50 https://www.ophthalmologytimes.com/view/top-ophthalmologists-anticipate-escrs-sessions 2022-09-16 0.50 https://www.ophthalmologytimes.com/view/monkeypox-may-be-linked-with-conjunctivitis 2022-09-13 0.50 https://www.ophthalmologytimes.com/view/a-new-lens-option-for-enhanced-monovision-performance 2022-10-12 0.50 https://www.ophthalmologytimes.com/view/congress-of-the-escrs-reaches-milestone-age 2022-09-07 0.50 https://www.ophthalmologytimes.com/view/interim-global-survey-analysis-reveals-opportunities-to-improve-patient-outcomes 2022-10-20 0.50 https://www.ophthalmologytimes.com/view/positive-interim-data-in-phase-2-behold-trial-investigating-ubx1325-in-dmo-patients 2022-10-04 0.50 https://www.ophthalmologytimes.com/view/time-is-retina-focus-on-the-ocular-aspects-of-neuromyelitis-optica 2022-09-08 0.50 https://www.ophthalmologytimes.com/view/fluid-monitor-utilises-ai-to-identify-localise-and-quantify-retinal-fluid 2022-09-06 0.50 https://www.ophthalmologytimes.com/view/multicentre-phase-3-clinical-trial-using-ai-in-namd-identifies-measures-fluid-volumes-in-real-time 2022-09-06 0.50 https://www.ophthalmologytimes.com/view/how-when-and-why-to-use-ai-in-the-clinical-management-of-namd 2022-09-06 0.50 https://www.ophthalmologytimes.com/view/new-insights-into-macular-carotenoid-accumulation-and-transport 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/bilateral-small-incision-lenticule-extraction-with-smile-pro-using-the-visumax-800 2025-06-05 0.50 https://www.ophthalmologytimes.com/view/euretina-2022-in-review-a-showcase-of-retinal-revelations-in-hamburg 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/music-creates-soothing-effect-for-babies-during-retinopathy-of-prematurity-examinations 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/first-analysis-of-gene-therapy-for-rpe65-inherited-retinal-dystrophies-shows-good-safety-efficacy 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/visual-symptoms-after-covid-19-suggest-retinal-involvement 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/link-discovered-between-retinitis-pigmentosa-and-increased-risk-of-primary-open-angle-glaucoma 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/managing-silicone-oil-related-complications-following-vitreoretinal-surgery 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/rgx-314-provided-2-step-or-more-improvement-in-diabetic-severity-in-phase-2-altitude-study-analysis 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/hair-cortisol-may-act-as-molecular-biomarker-for-retinitis-pigmentosa-patients 2022-09-01 0.50 https://www.ophthalmologytimes.com/view/euretina-leadership-discusses-what-to-expect-at-the-2022-congress-outlines-women-in-retina-programme 2022-08-31 0.50 https://www.ophthalmologytimes.com/view/addressing-glaucoma-during-routine-cataract-surgery-the-experts-opinions-on-the-role-of-elios 2023-03-03 0.50 https://www.ophthalmologytimes.com/view/fight-retinal-blindness-registry-data-ranibizumab-and-aflibercept-safe-for-treating-dmo-over-3-years 2022-08-30 0.50 https://www.ophthalmologytimes.com/view/short-term-corticosteroid-use-can-provide-rapid-relief-of-allergy-symptoms-in-dry-eye-disease 2022-08-29 0.50 https://www.ophthalmologytimes.com/view/euretina-celebrates-women-in-retina 2022-08-24 0.50 https://www.ophthalmologytimes.com/view/depression-stress-may-play-a-role-in-glaucoma-disease-progression 2022-08-26 0.50 https://www.ophthalmologytimes.com/view/novel-devices-drugs-trigger-rapid-glaucoma-market-expansion 2022-08-23 0.50 https://www.ophthalmologytimes.com/view/finalists-announced-in-euroversion-case-video-competition-for-vitreoretinal-fellows 2022-08-23 0.50 https://www.ophthalmologytimes.com/view/bariatric-surgery-may-result-in-less-sight-threatening-diabetic-retinopathy 2022-08-23 0.50 https://www.ophthalmologytimes.com/view/stepping-into-a-new-era-of-ophthalmology-at-euretina-2022 2022-08-19 0.50 https://www.ophthalmologytimes.com/view/link-discovered-between-myopia-poag-risk 2022-08-19 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-research-ushers-in-new-therapy-options-for-retinal-diseases 2022-08-17 0.50 https://www.ophthalmologytimes.com/view/cerebral-visual-impairment-getting-to-the-heart-of-paediatric-vision-loss 2022-08-17 0.50 https://www.ophthalmologytimes.com/view/averting-zonular-crises-in-different-types-of-cataract-patients 2022-08-15 0.50 https://www.ophthalmologytimes.com/view/applying-cryopreserved-amniotic-membrane-following-intravitreal-injection 2022-08-15 0.50 https://www.ophthalmologytimes.com/view/no-ocular-manifestations-associated-with-inflammatory-bowel-disease-study-finds 2022-08-12 0.50 https://www.ophthalmologytimes.com/view/phase-3-study-of-cpn-302-positive-topline-results-for-post-cataract-surgery-drug-candidate 2022-08-12 0.50 https://www.ophthalmologytimes.com/view/a-window-into-the-world-of-academic-retina-practice-today 2022-08-10 0.50 https://www.ophthalmologytimes.com/view/intravenous-bevacizumab-repackaged-for-intravitreal-use-making-the-sight-saving-treatment-safer 2022-08-15 0.50 https://www.ophthalmologytimes.com/view/the-pathophysiology-and-pathomorphology-of-corneal-ectasia-multimodal-imaging-techniques-yield-vital-screening-and-diagnostics-data 2022-08-04 0.50 https://www.ophthalmologytimes.com/view/the-need-for-precision-management-in-glaucoma-moves-field-forward 2022-08-04 0.50 https://www.ophthalmologytimes.com/view/high-tech-noninvasive-imaging-identifies-early-glaucoma 2022-08-05 0.50 https://www.ophthalmologytimes.com/view/first-ever-retinal-gene-therapy-does-real-world-experience-back-its-use- 2022-08-04 0.50 https://www.ophthalmologytimes.com/view/managing-recurrent-herpes-simplex-in-patients-undergoing-keratoconus-cxl 2022-08-02 0.50 https://www.ophthalmologytimes.com/view/good-vision-minimal-disturbances-achieved-with-presbyopia-iol 2022-08-04 0.50 https://www.ophthalmologytimes.com/view/gene-fragments-may-reveal-unexplained-causes-of-inherited-retinal-diseases 2022-07-27 0.50 https://www.ophthalmologytimes.com/view/identifying-viral-vectors-for-efficacious-gene-therapy-delivery-via-computational-platform 2022-07-27 0.50 https://www.ophthalmologytimes.com/view/black-and-white-filters-optimize-visualization-during-cataract-surgery 2022-07-27 0.50 https://www.ophthalmologytimes.com/view/no-additional-benefit-from-atropine-to-stop-axial-lengthening 2022-07-26 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-phase-2-optogenetic-gene-therapy-clinical-trial-for-stargardt-disease 2022-07-25 0.50 https://www.ophthalmologytimes.com/view/carl-zeiss-meditec-precise-bio-unveil-partnership-to-develop-tissue-based-corneal-transplants 2022-07-27 0.50 https://www.ophthalmologytimes.com/view/leveraging-uvc-light-for-infection-prevention-in-ophthalmology-and-beyond 2022-07-21 0.50 https://www.ophthalmologytimes.com/view/loss-of-pedf-may-prompt-aging-in-the-eye-finds-nei-study 2022-07-22 0.50 https://www.ophthalmologytimes.com/view/paediatric-eyes-repair-better-with-scleral-buckling-adults-need-vitrectomy-only-for-giant-retinal-tear-related-detachments 2023-07-12 0.50 https://www.ophthalmologytimes.com/view/regenerx-hlb-therapeutics-sign-letter-of-intent-for-phase-3-clinical-trials-in-neurotrophic-keratitis 2022-07-21 0.50 https://www.ophthalmologytimes.com/view/asrs-2022-in-review-new-data-on-dmo-amd-presented-at-this-year-s-meeting 2022-07-18 0.50 https://www.ophthalmologytimes.com/view/clinical-trials-in-wet-amd-impact-of-central-subfield-thickness-volatility-on-visual-acuity 2022-07-08 0.50 https://www.ophthalmologytimes.com/view/asrs-recap-presentations-from-16-july 2022-07-14 0.50 https://www.ophthalmologytimes.com/view/asrs-recap-15-july-presentations-in-review 2022-07-14 0.50 https://www.ophthalmologytimes.com/view/asrs-recap-what-was-presented-on-14-july 2022-07-18 0.50 https://www.ophthalmologytimes.com/view/post-hoc-analysis-of-copernicus-galileo-trials-find-time-since-diagnosis-affects-bcva-outcomes-in-crvo 2022-07-12 0.50 https://www.ophthalmologytimes.com/view/noninfectious-uveitis-uveitic-macular-edema-a-synopsis-of-frontline-therapies 2022-07-12 0.50 https://www.ophthalmologytimes.com/view/archway-phase-3-end-of-trial-results-show-port-delivery-system-is-noninferior-to-monthly-ranibizumab 2022-07-08 0.50 https://www.ophthalmologytimes.com/view/enrolment-begins-in-phase-2-study-for-therapeutic-for-persistent-corneal-epithelial-defects 2022-07-08 0.50 https://www.ophthalmologytimes.com/view/intraventricular-haemorrhage-in-first-year-may-lead-to-long-term-sight-problems 2022-07-06 0.50 https://www.ophthalmologytimes.com/view/asrs-2022-retina-revelations-in-nyc 2022-07-07 0.50 https://www.ophthalmologytimes.com/view/automated-screening-of-common-eye-disorders-helped-by-novel-deep-learning-model 2022-07-06 0.50 https://www.ophthalmologytimes.com/view/less-is-more-with-redesigned-probe-for-micropulse-tlt-for-glaucoma 2022-07-01 0.50 https://www.ophthalmologytimes.com/view/clinical-trial-offers-insight-into-development-of-ksi-301 2022-06-30 0.50 https://www.ophthalmologytimes.com/view/assessing-and-treating-the-rare-inherited-disease-achromatopsia 2022-06-14 0.50 https://www.ophthalmologytimes.com/view/phase-3-study-assesses-superiority-in-mean-bcva-in-opt-302-combination-therapy-over-anti-vegf-a-monotherapy 2022-06-30 0.50 https://www.ophthalmologytimes.com/view/researchers-find-association-between-glaucoma-and-chronic-kidney-disease 2022-06-29 0.50 https://www.ophthalmologytimes.com/view/hypersonic-vitrectomy-a-novel-technology-for-removing-vitreous 2022-06-28 0.50 https://www.ophthalmologytimes.com/view/significance-of-the-yosemite-and-rhine-2-year-dmo-clinical-trial-results 2022-06-27 0.50 https://www.ophthalmologytimes.com/view/self-plugging-microneedles-may-improve-drug-delivery-in-the-eye 2022-06-24 0.50 https://www.ophthalmologytimes.com/view/newly-identified-molecular-mechanism-may-lead-to-more-therapies-for-retinitis-pigmentosa 2022-06-24 0.50 https://www.ophthalmologytimes.com/view/ebola-other-viruses-may-be-housed-in-retina-cells 2022-06-24 0.50 https://www.ophthalmologytimes.com/view/is-retinal-tissue-preservation-as-important-as-decreased-ga-expansion-in-future-therapies- 2022-06-23 0.50 https://www.ophthalmologytimes.com/view/approaches-for-managing-treatment-of-patients-with-endophthalmitis 2022-06-21 0.50 https://www.ophthalmologytimes.com/view/link-discovered-between-eye-health-diet-and-lifespan 2022-06-20 0.50 https://www.ophthalmologytimes.com/view/ora-europe-executive-outlines-pathway-for-clinical-trials 2022-06-14 0.50 https://www.ophthalmologytimes.com/view/treat-to-maintain-drug-vorolanib-ushers-in-new-era-for-retinal-therapy 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/armor-study-evaluating-antibiotic-resistance-in-the-treatment-of-staph-infections 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/unravelling-the-mysteries-of-amblyopia-and-fixation-eye-movements 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/searching-for-uveitis-how-to-ensure-you-don-t-miss-a-diagnosis 2022-06-14 0.50 https://www.ophthalmologytimes.com/view/phase-1-trial-finds-at-home-subcutaneous-injection-option-safe-effective-for-the-treatment-of-wet-amd-dmo 2022-06-13 0.50 https://www.ophthalmologytimes.com/view/landscape-of-genetic-therapies-for-ush2a-related-retinitis-pigmentosa 2022-06-10 0.50 https://www.ophthalmologytimes.com/view/oc-01-varenicline-solution-investigated-as-possible-treatment-for-dry-eye-symptoms-signs 2022-06-10 0.50 https://www.ophthalmologytimes.com/view/cell-therapy-shows-promise-for-patients-with-dry-amd-geographic-atrophy 2022-06-10 0.50 https://www.ophthalmologytimes.com/view/new-technologies-improve-retinal-care-managing-patient-expectations-is-key 2022-06-08 0.50 https://www.ophthalmologytimes.com/view/retinal-blood-flow-biomarkers-measured-with-oct-doppler 2022-06-06 0.50 https://www.ophthalmologytimes.com/view/bringing-biologics-to-eye-health-regenerative-medicine-for-inflammatory-disorders 2022-06-07 0.50 https://www.ophthalmologytimes.com/view/binocular-vision-affected-by-amblyopia-research-suggests 2022-06-01 0.50 https://www.ophthalmologytimes.com/view/poag-study-hope-to-open-a-new-avenue-for-therapies-that-are-for-helping-treat-patients-that-develop-primary-open-angle-glaucoma 2022-06-06 0.50 https://www.ophthalmologytimes.com/view/predicting-optimal-treatment-regimen-for-patients-with-namd-using-machine-learning 2022-05-25 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-dbll-6-mg-approved-by-us-fda-for-treatment-of-diabetic-macular-oedema 2022-06-01 0.50 https://www.ophthalmologytimes.com/view/surgical-options-for-normalising-neuroadaptation 2022-05-31 0.50 https://www.ophthalmologytimes.com/view/advancements-in-cyclophotocoagulation-the-good-the-better-and-the-best 2022-05-31 0.50 https://www.ophthalmologytimes.com/view/the-pathophysiology-and-pathomorphology-of-corneal-ectasia-keratoconus-will-not-develop-without-eye-rubbing 2022-05-31 0.50 https://www.ophthalmologytimes.com/view/ill-timed-corneal-crosslinking-led-to-permanent-changes-in-corneal-structure-in-patients-with-keratoconus 2022-05-26 0.50 https://www.ophthalmologytimes.com/view/cost-of-treatment-discourages-adherence-for-patients-with-dry-eye-disease-associated-with-sj-gren-s-syndrome 2022-05-20 0.50 https://www.ophthalmologytimes.com/view/shedding-light-on-vitreous-opacities-during-cataract-surgery 2022-05-20 0.50 https://www.ophthalmologytimes.com/view/data-reveals-efficacy-of-bispecific-targeting-of-vegf-ang2-pathways 2022-05-19 0.50 https://www.ophthalmologytimes.com/view/mastering-the-yamane-technique-key-learnings-from-first-cases 2022-05-26 0.50 https://www.ophthalmologytimes.com/view/investigating-efficacy-of-oc-02-to-stimulate-the-trigeminal-nerve-for-the-treatment-of-dry-eyes 2022-05-20 0.50 https://www.ophthalmologytimes.com/view/integrated-study-phase-3-peachtree-azalea-indicate-significant-bcva-gains-cst-reduction 2022-05-20 0.50 https://www.ophthalmologytimes.com/view/advancing-iol-technology-for-treatment-of-presbyopia 2022-05-20 0.50 https://www.ophthalmologytimes.com/view/restoring-near-and-intermediate-vision-with-corneal-excimer-laser-surgery 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/approaching-pharmaceutical-treatment-for-cataracts 2022-05-19 0.50 https://www.ophthalmologytimes.com/view/strategic-alliance-combines-resources-to-develop-treatment-option-for-dry-eye-syndrome 2022-07-27 0.50 https://www.ophthalmologytimes.com/view/the-missing-link-in-the-recognition-of-corneal-abnormalities 2022-05-16 0.50 https://www.ophthalmologytimes.com/view/making-strides-in-ophthalmology-with-modern-gene-therapy-techniques 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/promising-early-data-with-intravitreal-diabetic-macular-ischaemia-candidate 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/acute-and-chronic-care-required-for-eye-with-sjs-ten-ocular-involvement 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/a-new-treatment-paradigm-with-ab-interno-canaloplasty-for-poag 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/half-a-century-of-developments-in-ophthalmology-one-doctor-s-reflections 2022-05-09 0.50 https://www.ophthalmologytimes.com/view/positive-topline-data-from-saturn-2-phase-3-trial-encourages-tarsus-to-file-nda-in-2022 2022-05-06 0.50 https://www.ophthalmologytimes.com/view/nanoemulsion-formulation-enhances-iop-reduction-study-finds 2022-05-06 0.50 https://www.ophthalmologytimes.com/view/2-year-yosemite-and-rhine-results-show-faricimab-reduces-treatment-burden-in-patients-with-dmo 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/testing-spectacle-lenses-for-myopia-control-in-relation-to-changes-in-axial-length 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/predicting-metastasis-with-novel-prognostic-liquid-biopsy-for-uveal-melanoma 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/diabetic-rats-protected-from-macular-oedema-hallmarks-with-thr-687-treatment 2022-04-29 0.50 https://www.ophthalmologytimes.com/view/tackling-today-s-top-challenges-of-clinical-research 2022-04-26 0.50 https://www.ophthalmologytimes.com/view/investigators-examine-long-term-effects-of-anti-vegf-injection-on-renal-function 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/relationship-between-dry-eye-disease-and-high-myopia-in-teenagers-investigated-in-study 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/unpacking-the-need-to-accelerate-clinical-studies-in-retina 2022-04-26 0.50 https://www.ophthalmologytimes.com/view/high-frequency-deep-sclerotomya-migs-procedure-for-mild-to-moderate-glaucoma 2022-05-03 0.50 https://www.ophthalmologytimes.com/view/sealing-masks-to-skin-with-tape-may-decrease-risk-of-ocular-surface-damage-during-the-covid-19-pandemic 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/injectable-axitnib-intravitreal-implant-delivers-high-drug-levels-to-retinal-tissue 2022-04-29 0.50 https://www.ophthalmologytimes.com/view/chronic-iop-elevation-affects-cerebrovascular-reactivity-in-murine-visual-cortex-linked-to-widespread-brain-changes 2022-05-02 0.50 https://www.ophthalmologytimes.com/view/bursts-of-intensive-outdoor-activity-result-in-increased-choroidal-central-corneal-thickness-in-paediatric-patients 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/bcva-anatomic-improvements-found-with-opt-302-combination-therapy-for-pcv 2022-04-26 0.50 https://www.ophthalmologytimes.com/view/cosmetic-iris-implants-pose-high-risk-of-vision-loss 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/taking-visual-field-analysis-to-a-higher-level-with-the-icare-compass-automated-perimeter 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/study-investigates-risk-of-children-with-unilateral-retinoblastoma-developing-germline-mutations 2022-04-28 0.50 https://www.ophthalmologytimes.com/view/noninvasive-retinal-stimulation-achieved-via-ultrasound 2022-04-27 0.50 https://www.ophthalmologytimes.com/view/dry-eye-pearls-for-young-ophthalmologists 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/not-just-for-eating-grapes-and-potatoes-help-surgery-trainees-hone-skills 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/amblyopia-and-fixation-eye-movements-uncovering-the-mystery 2022-04-25 0.50 https://www.ophthalmologytimes.com/view/biometry-101-capturing-the-accurate-power 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/medical-and-surgical-treatments-emerge-for-presbyopia 2022-04-19 0.50 https://www.ophthalmologytimes.com/view/up-and-coming-amd-treatments-from-intravitreal-injections-to-gene-therapy 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/intravitreal-injections-for-rop-prove-safe-effective-in-many-cases 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/first-paediatric-patient-dosed-in-brilliance-phase-1-2-clinical-trial-for-lca10 2022-04-12 0.50 https://www.ophthalmologytimes.com/view/weekly-review-in-ophthamology-april-9-april-15 2022-04-21 0.50 https://www.ophthalmologytimes.com/view/corneal-haze-after-corneal-cross-linking-associated-with-mitomycin-c 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/high-performance-microscopy-for-non-invasive-conjunctival-goblet-cell-examination-examined-by-study 2022-04-12 0.50 https://www.ophthalmologytimes.com/view/a-portable-solution-for-high-definition-slit-lamp-imaging 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/identifying-patients-at-high-risk-for-endophthalmitis-post-cataract-surgery 2022-04-22 0.50 https://www.ophthalmologytimes.com/view/first-miniject-surgery-completed-in-the-uk 2022-04-06 0.50 https://www.ophthalmologytimes.com/view/-focus-on-child-eye-health-initiative-introduced-by-iapb 2022-04-06 0.50 https://www.ophthalmologytimes.com/view/european-commission-approves-brolucizumab-6-mg-for-treatment-of-diabetic-macular-oedema 2022-04-06 0.50 https://www.ophthalmologytimes.com/view/retina-specialists-review-recent-developments-in-research-for-retinal-diseases 2022-03-31 0.50 https://www.ophthalmologytimes.com/view/rop-lower-dose-of-intravitreal-bevacizumab-performs-as-effectively-as-higher-dose 2022-03-30 0.50 https://www.ophthalmologytimes.com/view/addressing-covid-19-associated-fungal-eye-disease-in-india 2022-04-05 0.50 https://www.ophthalmologytimes.com/view/lowering-brolucizumab-associated-intraocular-inflammation-with-steroids 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/recognising-corneal-abnormalities-with-ps-oct 2022-04-01 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-phase-i-ii-trial-for-gene-therapy-candidate-ocu400-for-inherited-retinal-degeneration 2022-04-01 0.50 https://www.ophthalmologytimes.com/view/ophthalmologists-in-new-zealand-disciplined-for-not-following-covid-19-mandates 2022-03-30 0.50 https://www.ophthalmologytimes.com/view/extended-depth-of-field-lenses-understanding-a-new-player-in-cataract-surgery 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/first-patient-treated-in-trident-european-trial 2022-03-29 0.50 https://www.ophthalmologytimes.com/view/preventing-posterior-capsule-opacification-in-paediatric-cataract-surgery 2022-03-25 0.50 https://www.ophthalmologytimes.com/view/very-high-frequency-ultrasound-improves-icl-sizing-precision 2022-03-25 0.50 https://www.ophthalmologytimes.com/view/japanese-investigators-identify-gene-required-for-survival-of-retinal-ganglion-cells 2022-03-25 0.50 https://www.ophthalmologytimes.com/view/acute-covid-19-does-not-affect-corneal-sensitivity-study-finds 2022-03-25 0.50 https://www.ophthalmologytimes.com/view/maximal-therapy-with-netarsudil-lowers-iop-for-patients 2022-03-25 0.50 https://www.ophthalmologytimes.com/view/study-reveals-cell-fusion-stimulates-regenerative-potential-in-the-retina 2022-03-23 0.50 https://www.ophthalmologytimes.com/view/seasonal-allergies-are-a-common-trigger-for-dry-eye-flares 2022-03-17 0.50 https://www.ophthalmologytimes.com/view/bimatoprost-implant-reduces-intraocular-pressure-for-2-years-or-more 2022-03-15 0.50 https://www.ophthalmologytimes.com/view/novel-gene-therapy-offers-vision-gains-for-x-linked-retinitis-pigmentosa 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/sound-stimulates-blind-retina-to-transmit-signals-to-the-brain-in-new-study 2022-03-17 0.50 https://www.ophthalmologytimes.com/view/depression-may-influence-severity-of-dry-eye-symptoms-inflammatory-markers 2022-03-17 0.50 https://www.ophthalmologytimes.com/view/genetic-testing-may-be-the-key-to-identifying-keratoconus-suspects 2022-03-29 0.50 https://www.ophthalmologytimes.com/view/austrian-study-targets-dry-eye-disease-in-postmenopausal-women 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/phase-ii-corneal-health-clinical-program-initiated-for-pharmaceutical-platform 2022-03-14 0.50 https://www.ophthalmologytimes.com/view/retinal-microvascular-changes-may-not-predict-short-term-ischaemic-insults 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/top-tips-for-young-ophthalmologists-negotiating-contracts 2022-03-02 0.50 https://www.ophthalmologytimes.com/view/treating-persistent-epithelial-defects-and-pushing-toward-healing 2022-03-14 0.50 https://www.ophthalmologytimes.com/view/brain-cells-impacted-by-glaucoma-may-be-protected-by-sigma-1-receptor 2022-03-04 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-department-hit-in-hospital-bombing-in-ukraine 2022-03-10 0.50 https://www.ophthalmologytimes.com/view/gonio-intervention-robot-assisted-glaucoma-surgical-procedure-offers-high-precision 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/pilot-project-aims-to-overcome-inequalities-in-glaucoma-diagnoses 2022-03-29 0.50 https://www.ophthalmologytimes.com/view/creating-precise-goniotomies-with-novel-surgical-system 2022-03-07 0.50 https://www.ophthalmologytimes.com/view/simplifying-glaucoma-medical-therapy-for-patients-in-the-united-states 2022-03-08 0.50 https://www.ophthalmologytimes.com/view/world-glaucoma-week-celebrating-strides-in-surgical-techniques-and-therapeutics 2022-03-04 0.50 https://www.ophthalmologytimes.com/view/leave-the-drops-behind-finding-the-glaucoma-treatment-that-is-best-for-your-patient 2022-03-04 0.50 https://www.ophthalmologytimes.com/view/viral-vector-contract-development-cgmp-manufacturing-partnership-announced-between-ray-therapeutics-forge-biologics 2022-03-04 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-exudation-and-degeneration-2022-spotlighting-major-advances-in-retinal-diagnostics-and-therapies 2022-03-08 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-and-the-climate-crisis-time-to-take-responsibility 2022-03-08 0.50 https://www.ophthalmologytimes.com/view/robot-assisted-glaucoma-surgery-brings-a-taste-of-the-future-to-today 2022-02-25 0.50 https://www.ophthalmologytimes.com/view/novel-presbyopia-correcting-iol-comparing-clinical-outcomes-from-multinational-investigations 2022-02-24 0.50 https://www.ophthalmologytimes.com/view/celebrating-the-progression-of-treatment-for-inherited-retinal-diseases-on-rare-disease-day 2022-02-28 0.50 https://www.ophthalmologytimes.com/view/poag-ocular-implant-met-primary-secondary-endpoints-in-phase-2a-study 2022-02-25 0.50 https://www.ophthalmologytimes.com/view/paladin-study-improved-visual-acuity-cst-resulting-from-fluocinolone-acetonide-intravitreal-implant 2022-02-24 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-therapy-slows-progression-of-severe-npdr-in-monte-carlo-simulation-model 2022-02-21 0.50 https://www.ophthalmologytimes.com/view/rethinking-dry-eye-disease-with-acute-steroid-treatment 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/studying-teprotumumab-adherence-in-patients-with-thyroid-eye-disease 2022-03-14 0.50 https://www.ophthalmologytimes.com/view/combining-laser-with-minimally-invasive-glaucoma-surgery-to-impact-iop 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/simplifying-cataract-surgery-in-patients-with-poor-mydriasis-compromised-zonules 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/the-retina-may-reveal-risk-of-alzheimer-disease-in-middle-age 2022-02-18 0.50 https://www.ophthalmologytimes.com/view/gene-therapies-licensed-by-kriya-therapeutics-target-geographic-atrophy-other-ocular-diseases 2022-02-17 0.50 https://www.ophthalmologytimes.com/view/pds-a-new-era-in-the-treatment-of-wet-amd 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/high-dose-aflibercept-shows-improvement-for-wet-amd-patients-in-candela 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/dextenza-approval-in-us-provides-new-allergic-conjunctivitis-option 2022-02-14 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2022-review-research-makes-strides-in-geographic-atrophy-diabetic-eye-disease 2022-02-14 0.50 https://www.ophthalmologytimes.com/view/hope-for-stargardt-on-the-horizon-rna-therapy-holds-promise 2022-02-04 0.50 https://www.ophthalmologytimes.com/view/investigating-stargardt-rna-gene-therapy-options-for-patients 2022-02-09 0.50 https://www.ophthalmologytimes.com/view/kestrel-kite-studies-100-week-results-of-brolucizumab-investigation 2022-02-09 0.50 https://www.ophthalmologytimes.com/view/kalahari-results-indicate-bcva-increase-stable-cst-in-high-dose-group 2022-02-11 0.50 https://www.ophthalmologytimes.com/view/thr-149-demonstrated-to-be-safe-well-tolerated-for-treatment-of-dmo 2022-02-11 0.50 https://www.ophthalmologytimes.com/view/leveraging-deep-learning-for-diabetic-retinopathy-detection-with-ultra-wide-field-imaging 2022-02-09 0.50 https://www.ophthalmologytimes.com/view/faricimab-for-dmo-safe-durable-treatment-over-the-long-term 2022-02-12 0.50 https://www.ophthalmologytimes.com/view/portal-extension-trial-pds-maintains-visual-and-anatomic-benefits-over-long-term 2022-02-12 0.50 https://www.ophthalmologytimes.com/view/safety-results-for-davio-trial-positive-outcomes-for-eyp-1901-for-wet-amd 2022-02-04 0.50 https://www.ophthalmologytimes.com/view/staying-at-the-top-optimizing-clinical-care-and-practice-efficiency-with-multimodal-triton-imaging 2022-02-16 0.50 https://www.ophthalmologytimes.com/view/exploring-the-link-between-choriocapillaris-atrophy-and-neovascular-amd 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/avacincaptad-pegol-slows-growth-of-geographic-atrophy-lesions-for-patients-in-clinical-trial 2022-02-11 0.50 https://www.ophthalmologytimes.com/view/updates-on-focus-trial-cfi-supplementing-gene-therapy-in-ga 2022-02-07 0.50 https://www.ophthalmologytimes.com/view/subretinal-implant-for-advanced-dry-amd-determined-to-be-safe-well-tolerated 2022-01-31 0.50 https://www.ophthalmologytimes.com/view/blocking-connexin-43-may-improve-diabetic-retinopathy-amd 2022-02-07 0.50 https://www.ophthalmologytimes.com/view/once-daily-oral-dosing-a-future-boon-for-patients-with-dmo-ga-kidney-disease 2022-01-31 0.50 https://www.ophthalmologytimes.com/view/updates-from-angiogenesis-2022 2022-03-03 0.50 https://www.ophthalmologytimes.com/view/vivid-vista-how-baseline-factors-affect-dmo-resolution 2022-02-07 0.50 https://www.ophthalmologytimes.com/view/home-monitoring-of-wet-amd-offers-high-quality-scans 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/digital-visual-training-helps-treat-disorders-associated-with-close-work 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/tearclear-initiates-phase-3-clinical-trial-of-tc-002 2022-02-07 0.50 https://www.ophthalmologytimes.com/view/a-simple-solution-for-complex-corneas 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/heidelberg-engineering-becomes-member-of-glaucoma-myopia-oct-phenotyping-consortium 2022-02-04 0.50 https://www.ophthalmologytimes.com/view/corneal-crosslinking-and-epithelial-management-four-pearls-for-success 2022-02-02 0.50 https://www.ophthalmologytimes.com/view/joining-forces-to-increase-effective-gene-therapies-for-rare-diseases 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/deep-sclerectomy-surgery-trumps-traditional-techniques 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/dexamethasone-insert-reduces-time-spent-planning-cataract-surgery-counselling-patients 2022-01-27 0.50 https://www.ophthalmologytimes.com/view/experiencing-the-presbylasik-procedure-as-both-surgeon-and-patient 2022-02-08 0.50 https://www.ophthalmologytimes.com/view/investigators-estimate-that-30-of-wet-amd-patients-could-safely-stop-eye-injections 2022-01-25 0.50 https://www.ophthalmologytimes.com/view/smart-harness-alerts-visually-impaired-people-to-obstacles-in-their-paths 2022-01-18 0.50 https://www.ophthalmologytimes.com/view/faricimab-approved-by-us-fda-for-treatment-of-wet-amd-dmo 2022-01-29 0.50 https://www.ophthalmologytimes.com/view/intravitreal-triamcinolone-effectively-manages-dmo-and-increases-vision-study-reports 2022-01-21 0.50 https://www.ophthalmologytimes.com/view/diffractive-multifocal-iol-linked-with-progressive-decline-in-vision-in-aging-patients 2022-01-20 0.50 https://www.ophthalmologytimes.com/view/phase-3-norse-two-proves-ophthalmic-bevacizumab-effectively-treats-wet-macular-degeneration 2022-01-26 0.50 https://www.ophthalmologytimes.com/view/what-to-expect-at-angiogenesis-2022-fruitful-discussion-revolutionary-therapies 2022-01-31 0.50 https://www.ophthalmologytimes.com/view/differences-in-pupil-sizes-distinguish-between-active-and-resolved-covid-19-cases 2022-01-14 0.50 https://www.ophthalmologytimes.com/view/consuming-dried-goji-berries-may-protect-against-amd 2022-01-19 0.50 https://www.ophthalmologytimes.com/view/foundation-fighting-blindness-promotes-jason-menzo-to-president-coo 2022-01-20 0.50 https://www.ophthalmologytimes.com/view/retinal-age-gap-linked-to-heightened-death-risk-study-finds 2022-01-20 0.50 https://www.ophthalmologytimes.com/view/removing-opioid-prescriptions-from-cataract-surgery 2022-01-14 0.50 https://www.ophthalmologytimes.com/view/iscan-80-oct-to-launch-in-uk 2022-01-19 0.50 https://www.ophthalmologytimes.com/view/staying-at-the-top-empowering-providers-with-the-multimodal-maestro2 2022-01-25 0.50 https://www.ophthalmologytimes.com/view/managing-long-covid-19-symptoms-that-persist-beyond-infection 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/x-linked-retinitis-pigmentosa-unravelling-the-burdens-of-the-inherited-retinal-disease 2021-12-13 0.50 https://www.ophthalmologytimes.com/view/delving-into-ancillary-testing-frequency-based-on-the-iris-registry 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/electronic-health-records-how-the-pandemic-highlighted-the-future-of-practice-management 2021-12-14 0.50 https://www.ophthalmologytimes.com/view/investigating-best-practices-for-micropulse-transscleral-therapy-for-glaucoma 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/central-subfield-thickness-fluctuations-in-dmo-may-predict-worse-va 2021-12-20 0.50 https://www.ophthalmologytimes.com/view/toric-iols-for-beginners-what-to-consider-before-and-during-surgery-and-in-the-postoperative-period 2021-12-10 0.50 https://www.ophthalmologytimes.com/view/inflammation-link-discovered-between-lupus-and-macular-degeneration 2021-12-20 0.50 https://www.ophthalmologytimes.com/view/exploring-sustained-drug-delivery-options-in-ophthalmology 2021-12-13 0.50 https://www.ophthalmologytimes.com/view/study-finds-virtual-reality-paradigm-viable-for-orientation-mobility-testing 2021-12-20 0.50 https://www.ophthalmologytimes.com/view/renal-function-could-be-a-predictor-for-poor-treatment-response-in-patients-with-dmo 2021-12-14 0.50 https://www.ophthalmologytimes.com/view/optimising-visual-function-in-keratoconus 2021-12-10 0.50 https://www.ophthalmologytimes.com/view/dry-eye-disease-causes-imbalance-of-neuropeptides-neurotrophins-in-cornea-trigeminal-ganglion 2021-12-16 0.50 https://www.ophthalmologytimes.com/view/bimatoprost-implant-successfully-lowers-iop-in-phase-3-of-the-artemis-study 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/repeatable-high-quality-imaging-leads-to-better-diabetic-eye-disease-management 2021-12-15 0.50 https://www.ophthalmologytimes.com/view/using-acute-steroid-treatment-for-dry-eye-disease 2021-12-14 0.50 https://www.ophthalmologytimes.com/view/updates-on-brolucizumab-for-treatment-of-wet-amd-and-dmo 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/aerie-santen-create-commercialization-and-development-agreement-for-rhopressa-rocklatan 2021-12-10 0.50 https://www.ophthalmologytimes.com/view/recent-innovations-are-improving-surgical-outcomes-in-young-patients 2021-12-06 0.50 https://www.ophthalmologytimes.com/view/clinical-implications-of-port-delivery-system-in-retinal-diseases 2021-12-15 0.50 https://www.ophthalmologytimes.com/view/shedding-light-on-antibiotic-resistance-in-ophthalmology-with-armor-study-data 2021-12-07 0.50 https://www.ophthalmologytimes.com/view/teleretinal-screening-for-diabetic-retinopathy-provides-effective-disease-monitoring 2021-12-01 0.50 https://www.ophthalmologytimes.com/view/oct-octa-ocular-biomarkers-may-help-diagnose-parkinson-s-disease 2021-12-10 0.50 https://www.ophthalmologytimes.com/view/pds-in-retinal-diseases-practical-advice-on-education-and-training 2021-12-15 0.50 https://www.ophthalmologytimes.com/view/happy-retirement-barb- 2021-12-09 0.50 https://www.ophthalmologytimes.com/view/collagen-crosslinking-provides-corneal-stability-in-young-patients 2021-12-06 0.50 https://www.ophthalmologytimes.com/view/cell-therapy-for-corneal-endothelial-disease-proves-successful-in-japan-el-salvador 2021-12-13 0.50 https://www.ophthalmologytimes.com/view/phase-1-study-results-for-new-sustained-release-anti-vegf-formulation-eyp-1901 2022-01-27 0.50 https://www.ophthalmologytimes.com/view/phase-2-vivid-study-presents-positive-topline-data-for-presbyopia-treatment-options 2021-12-01 0.50 https://www.ophthalmologytimes.com/view/rapid-safe-nhs-eye-care-provided-by-moorfields-ucl-at-brent-cross-shopping-centre 2021-12-07 0.50 https://www.ophthalmologytimes.com/view/ophthalmic-challenges-in-2022-automation-developments-pandemic-backlogs-and-regulatory-issues-expected 2021-12-06 0.50 https://www.ophthalmologytimes.com/view/pds-in-retinal-diseases-interpreting-the-ladder-and-archway-studies 2021-12-02 0.50 https://www.ophthalmologytimes.com/view/newer-cpc-laser-technologies-are-improving-glaucoma-outcomes 2021-12-06 0.50 https://www.ophthalmologytimes.com/view/identifying-individuals-at-risk-of-glaucoma-via-genetics-studies 2021-12-06 0.50 https://www.ophthalmologytimes.com/view/current-approaches-to-treatment-of-uveitis-with-autoimmune-disease 2021-11-30 0.50 https://www.ophthalmologytimes.com/view/a-new-look-at-astigmatism-correction-in-cataract-surgery 2021-12-01 0.50 https://www.ophthalmologytimes.com/view/pds-and-rgx-314-two-new-surgical-procedures-for-the-treatment-of-wet-amd 2021-11-24 0.50 https://www.ophthalmologytimes.com/view/the-development-and-safety-of-port-delivery-system-in-retinal-diseases 2021-11-29 0.50 https://www.ophthalmologytimes.com/view/phase-2b-study-results-of-ar-15512-for-the-treatment-of-dry-eye 2021-12-02 0.50 https://www.ophthalmologytimes.com/view/managing-senior-specific-complications-of-diabetic-eye-disease 2021-11-24 0.50 https://www.ophthalmologytimes.com/view/toric-iols-for-beginners-advice-on-selecting-and-calculating-toric-iol-sphere-and-cylinder-power 2021-11-16 0.50 https://www.ophthalmologytimes.com/view/verana-health-s-new-quality-measures-dashboard-unveiled-at-aao-2021 2021-11-24 0.50 https://www.ophthalmologytimes.com/view/achieving-more-predictable-visual-recovery-following-glaucoma-surgery 2021-11-16 0.50 https://www.ophthalmologytimes.com/view/children-s-vision-equity-alliance-formed-by-prevent-blindness-s-national-centre-for-children-s-vision-and-eye-health 2021-11-18 0.50 https://www.ophthalmologytimes.com/view/addressing-gaps-in-vision-care-with-a-wearable-diagnostic-platform 2021-11-24 0.50 https://www.ophthalmologytimes.com/view/new-iol-offers-patients-greater-spectacle-independence-over-wider-range 2021-11-16 0.50 https://www.ophthalmologytimes.com/view/review-of-findings-presented-at-the-american-academy-of-ophthalmology-annual-meeting 2021-11-14 0.50 https://www.ophthalmologytimes.com/view/drug-delivery-to-retina-via-port-delivery-system-is-efficient-for-patients-with-wet-amd 2021-11-15 0.50 https://www.ophthalmologytimes.com/view/universal-face-masking-reduces-endophthalmitis-incidence-during-anti-vegf-injections 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/dmo-study-finds-faricimab-provides-sustained-retinal-stability 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/plasma-metabolomic-profiles-could-predict-amd-progression 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/presbyopia-correcting-drops-provide-hope-for-frustrated-patients 2021-11-16 0.50 https://www.ophthalmologytimes.com/view/central-subfield-thickness-changes-linked-to-worse-visual-outcomes-in-dmo 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/though-rare-ocular-surface-tumours-often-prove-deadly 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/study-reports-that-optic-nerve-pallor-is-prevalent-in-zika-virus-patients 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/study-of-bimatoprost-implant-reports-iop-reduction-for-2-years-or-more 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/dosing-variability-with-pre-filled-syringes-of-aflibercept-presents-risk-of-overdose 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/dmo-treatment-brolucizumab-proves-noninferior-to-aflibercept-requires-fewer-injections 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/mitomycin-c-associated-with-increase-in-corneal-haze-after-corneal-crosslinking 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/study-proves-intra-arterial-tissue-plasminogen-activator-beneficial-for-treatment-of-central-retinal-artery-occlusion 2021-11-14 0.50 https://www.ophthalmologytimes.com/view/president-john-saharek-the-imprimisrx-pipeline-details-3-products 2021-11-11 0.50 https://www.ophthalmologytimes.com/view/aao-2021-kicks-off-in-the-big-easy 2021-11-11 0.50 https://www.ophthalmologytimes.com/view/assessing-the-quality-of-real-world-evidence-in-retinal-diseases 2021-11-17 0.50 https://www.ophthalmologytimes.com/view/5-year-followup-data-for-study-on-combining-anterior-and-posterior-segment-surgery 2021-11-08 0.50 https://www.ophthalmologytimes.com/view/the-impact-of-covid-19-on-chinese-ophthalmology-at-the-start-of-the-pandemic 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/corneal-mechanical-sensitivity-in-individuals-with-chronic-pain 2021-11-05 0.50 https://www.ophthalmologytimes.com/view/eye-drops-for-treatment-of-presbyopia-approved-by-us-fda 2021-11-02 0.50 https://www.ophthalmologytimes.com/view/efficacy-of-pegcetacoplan-in-geographic-atrophy-oaks-and-derby-phase-3-results 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/macrophage-mediated-cytokine-storm-associated-with-covid-19-infection-in-diabetic-patients 2021-11-02 0.50 https://www.ophthalmologytimes.com/view/traversing-the-history-of-the-port-delivery-system 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/fluocinolone-acetonide-implants-in-dmo-decrease-need-for-anti-vegf-supplementation 2021-11-03 0.50 https://www.ophthalmologytimes.com/view/the-role-of-the-femtosecond-laser-in-paediatric-cataract-surgery 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/african-american-glaucoma-study-targets-gene-therapy-options 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/high-incidence-of-cognitive-deficits-brain-fog-following-covid-19-infection 2021-10-28 0.50 https://www.ophthalmologytimes.com/view/phase-2-study-results-of-ar-1105-therapy-in-macular-oedema-secondary-to-retinal-vein-occlusion 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/challenges-with-screening-dry-eye-patients-for-sj-gren-s-syndrome 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/broadening-the-benefits-of-icare-eidon-retinal-imaging-with-the-new-ultra-wide-field-module 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/code-free-deep-learning-the-next-phase-of-ai-enabled-healthcare- 2021-10-25 0.50 https://www.ophthalmologytimes.com/view/updates-from-asrs-2021 2022-01-03 0.50 https://www.ophthalmologytimes.com/view/triamcinolone-acetonide-for-suprachoroidal-injection-for-treatment-of-uveitic-macular-oedema-approved-by-us-fda 2021-10-27 0.50 https://www.ophthalmologytimes.com/view/genentech-s-susvimo-formerly-pds-with-ranibizumab-receives-us-fda-approval 2021-10-25 0.50